Published in Scand J Immunol on November 01, 1984
C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect Immun (1996) 2.77
Cloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor. J Bacteriol (1992) 2.14
Association between expression of immunoglobulin G-binding proteins by group A streptococci and virulence in a mouse skin infection model. Infect Immun (1993) 1.92
A novel sortase, SrtC2, from Streptococcus pyogenes anchors a surface protein containing a QVPTGV motif to the cell wall. J Bacteriol (2004) 1.38
Analysis of genes encoding two unique type IIa immunoglobulin G-binding proteins expressed by a single group A streptococcal isolate. Infect Immun (1994) 1.20
Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64. Infect Immun (2000) 1.13
Identification of non-immunoglobulin A-Fc-binding forms and low-molecular-weight secreted forms of the group B streptococcal beta antigen. Infect Immun (1989) 1.12
Association of type II immunoglobulin G-binding protein expression and survival of group A streptococci in human blood. Infect Immun (1993) 1.10
Functional and serological analysis of type II immunoglobulin G-binding proteins expressed by pathogenic group A streptococci. J Clin Microbiol (1992) 1.08
Streptococcus pyogenes infection in mouse skin leads to a time-dependent up-regulation of protein H expression. Infect Immun (2003) 0.86
Colloidal gold immunolabeling of immunoglobulin-binding sites and beta antigen in group B streptococci. Infect Immun (1990) 0.79
Streptococcal anti-desoxyribonuclease B: microtechnique determination. J Lab Clin Med (1968) 3.88
The influence of the site of infection on the immune response to group A streptococci. J Clin Invest (1970) 3.07
IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Clin Exp Immunol (1986) 2.36
Group A streptococcal growth phase-associated virulence factor regulation by a novel operon (Fas) with homologies to two-component-type regulators requires a small RNA molecule. Mol Microbiol (2001) 2.24
Cloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor. J Bacteriol (1992) 2.14
Experimental IgA nephropathy. J Exp Med (1979) 2.09
Persistence of streptococcal group A antibody in patients with rheumatic valvular disease. J Exp Med (1968) 1.95
Rectal colonization with group B streptococcus: relation to vaginal colonization of pregnant women. J Infect Dis (1977) 1.94
Association between expression of immunoglobulin G-binding proteins by group A streptococci and virulence in a mouse skin infection model. Infect Immun (1993) 1.92
Juvenile rheumatoid arthritis in velo-cardio-facial syndrome: coincidence or unusual complication? Am J Med Genet (1996) 1.83
Capturing host plasmin(ogen): a common mechanism for invasive pathogens? Trends Microbiol (1994) 1.76
Maternal-infant transfer of influenza-specific immunity in the mouse. J Immunol (1983) 1.76
Identification of a specific receptor for plasmin on a group A streptococcus. Infect Immun (1987) 1.72
M-related protein (Mrp) contributes to group A streptococcal resistance to phagocytosis by human granulocytes. Mol Microbiol (1996) 1.71
Transfer factor in the treatment of a case of chronic mucocutaneous candidiasis. Cell Immunol (1972) 1.55
Immunoglobulin-binding activity among pathogenic and carrier isolates of Haemophilus somnus. Infect Immun (1989) 1.52
A comparison of ampicillin and chloramphenicol therapy in Hemophilus influenzae meningitis. Pediatrics (1971) 1.48
Identification of pel, a Streptococcus pyogenes locus that affects both surface and secreted proteins. J Bacteriol (1999) 1.39
Isolation of a prokaryotic plasmin receptor. Relationship to a plasminogen activator produced by the same micro-organism. J Biol Chem (1991) 1.38
A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties. Res Microbiol (1998) 1.36
The unusual severity of Mycoplasmal pneumonia in children with sickle-cell disease. N Engl J Med (1972) 1.35
Streptococcal Fc receptors. I. Isolation and partial characterization of the receptor from a group C streptococcus. J Immunol (1984) 1.33
Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: a multicenter randomized controlled trial. J Pediatr (1986) 1.28
Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs. Pediatr Infect Dis J (1987) 1.26
The fate of group A streptococci following phagocytosis. In vitro phagocytic studies of isotope-labeled streptococci. J Immunol (1967) 1.21
Lack of effect of Lactobacillus on gastrointestinal bacterial colonization in premature infants. Pediatr Infect Dis (1987) 1.21
High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. Am J Psychiatry (1989) 1.21
Intraphagocytic degradation of group A streptococci: electron microsopic studies. J Bacteriol (1969) 1.20
Characterization of the interaction of human plasmin with its specific receptor on a group A streptococcus. Microb Pathog (1988) 1.20
Isolation and characterization of type IIa and type IIb Fc receptors from a group A streptococcus. Scand J Immunol (1986) 1.18
Use of bisulfite in the streptococcal anti-nicotinamide adenine dinucleotidase test. Appl Microbiol (1966) 1.17
Intraphagocytic beta-N-acetylglucosaminidase. Properties of the enzyme and its activity on group A streptococcal carbohydrate in comparison with a soil bacillus enzyme. J Exp Med (1968) 1.16
IgG and IgM pneumococcal polysaccharide antibody responses in infants. Pediatr Res (1984) 1.16
Human monoclonal antibodies reactive with antigens of the group A Streptococcus and human heart. J Immunol (1988) 1.15
Successful treatment of systemic Chromobacterium violaceum infection. JAMA (1974) 1.15
Streptokinase-producing streptococci grown in human plasma acquire unregulated cell-associated plasmin activity. J Infect Dis (1992) 1.15
Erythromycin prophylaxis for pertussis. Pediatrics (1977) 1.14
Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64. Infect Immun (2000) 1.13
Periorbital and orbital cellulitis in children. Pediatrics (1978) 1.13
Identification of non-immunoglobulin A-Fc-binding forms and low-molecular-weight secreted forms of the group B streptococcal beta antigen. Infect Immun (1989) 1.12
Protection of mice from group A streptococcal skin infection by interleukin-12. J Infect Dis (1995) 1.12
Anaphylactoid purpura: streptococcal antibody titers and beta1c-globulin levels. J Pediatr (1969) 1.11
125I protein A: applications to the quantitative determination of fluid phase and cell-bound IgG. J Immunol Methods (1977) 1.10
Association of type II immunoglobulin G-binding protein expression and survival of group A streptococci in human blood. Infect Immun (1993) 1.10
Immune response of the human respiratory tract. II. Cell-mediated immunity in the lower respiratory tract to tuberculin and mumps and influenza viruses. J Infect Dis (1973) 1.10
Cellular immune responses to extracellular streptococcal products in rheumatic heart disease. J Clin Invest (1981) 1.10
Factors influencing adherence of group B streptococci to human vaginal epithelial cells. Infect Immun (1979) 1.10
Properties of extracellular neuraminidase produced by group A streptococcus. Infect Immun (1979) 1.09
Studies on the terminal stages of immune hemolysis. VI. Osmotic blockers of differing Stokes' radii detect complement-induced transmembrane channels of differing size. J Immunol (1979) 1.09
Functional and serological analysis of type II immunoglobulin G-binding proteins expressed by pathogenic group A streptococci. J Clin Microbiol (1992) 1.08
Two novel antigens associated with group B streptococci identified by a rapid two-stage radioimmunoassay. J Infect Dis (1988) 1.07
In vitro screening for antiretroviral agents against simian immunodeficiency virus (SIV). Antiviral Res (1990) 1.07
Measurement of leukocyte chemotaxis in vivo. Methods Enzymol (1988) 1.07
Isolation and partial characterization of a type II Fc receptor from a group A streptococcus. Mol Cell Biochem (1986) 1.07
Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest (1986) 1.06
Streptococcal Fc receptors. II. Comparison of the reactivity of a receptor from a group C streptococcus with staphylococcal protein A. J Immunol (1984) 1.06
Toxic shock syndrome caused by a strain of Staphylococcus aureus that produces enterotoxin C but not toxic shock syndrome toxin-1. Am J Dis Child (1989) 1.05
Evidence for functional heterogeneity in IgG Fc-binding proteins associated with group A streptococci. J Immunol (1991) 1.05
Non-immune immunoglobulin binding by "Haemophilus somnus". J Med Microbiol (1988) 1.05
Group B streptococcal C protein-associated antigens: association with neonatal sepsis. J Infect Dis (1991) 1.04
Hypoimmunoglobulinemia with normal T cell function in female siblings. Clin Immunol Immunopathol (1977) 1.03
Identification of two type IIa IgG-binding proteins expressed by a single group A streptococcus. J Immunol (1992) 1.02
Mapping of the human plasmin domain recognized by the unique plasmin receptor of group A streptococci. Infect Immun (1989) 1.02
Studies on the terminal stages of immune hemolysis. III. Distinction between the insertion of C9 and the formation of a transmembrane channel. J Immunol (1978) 1.02
Interaction between group A streptococci and the plasmin(ogen) system promotes virulence in a mouse skin infection model. J Infect Dis (1999) 0.99
Properties of IgG-binding proteins expressed by Streptococcus pyogenes isolates are predictive of invasive potential. J Infect Dis (1996) 0.99
Detection of receptors for the Fc region of IgG on streptococci. J Immunol Methods (1983) 0.99
Isolated DNA repeat region from fcrA76, the Fc-binding protein gene from an M-type 76 strain of group A streptococci, encodes a protein with Fc-binding activity. Mol Microbiol (1990) 0.99
Differences in antibody response to streptococcal antigens in children with rheumatic and non-rheumatic mitral valve disease. Circulation (1974) 0.99
A role for fibrinogen in the streptokinase-dependent acquisition of plasmin(ogen) by group A streptococci. J Infect Dis (1995) 0.98
Identification of a unique receptor on a group A streptococcus for the Fc region of human IgG3. J Immunol (1986) 0.98
Mycoplasmacidal effect of polymorphonuclear leukocyte extract. J Immunol (1969) 0.98
The potential role for nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. Methods (2000) 0.98
A group A streptococcal Enn protein potentially resulting from intergenomic recombination exhibits atypical immunoglobulin-binding characteristics. Mol Microbiol (1994) 0.97
Analysis of the interaction of group A streptococci with fibrinogen, streptokinase and plasminogen. Microb Pathog (1995) 0.97
Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo. J Immunol (1985) 0.96
Studies on the terminal stages of immune hemolysis. V. Evidence that not all complement-produced transmembrane channels are equal. J Immunol (1979) 0.96
Studies on the interaction between protein A and immunoglobulin G. II. Composition and activity of complexes formed between protein A and IgG. J Immunol (1978) 0.96
Poststreptococcal reactive arthritis: clinical characteristics and association with HLA-DR alleles. Arthritis Rheum (1998) 0.96
Identification of key gene products required for acquisition of plasmin-like enzymatic activity by group A streptococci. J Infect Dis (1997) 0.95
Differences in cell-bound C8 sites on chicken erythrocytes measured by their reactivity with guinea pig and human C9. J Immunol (1980) 0.95
Cloning and expression of genes encoding Haemophilus somnus antigens. Infect Immun (1988) 0.95
Community-wide outbreak of group G streptococcal pharyngitis. Pediatrics (1991) 0.95
Mouse skin passage of a Streptococcus pyogenes Tn917 mutant of sagA/pel restores virulence, beta-hemolysis and sagA/pel expression without altering the position or sequence of the transposon. BMC Microbiol (2001) 0.95
Lysis of tumor cells by antibody and complement. VII. Complement-dependent 86Rb release--a nonlethal event? J Immunol (1976) 0.94
Production of Brucella abortus-specific protein A-reactive antibodies (IgG2) in infected and vaccinated cattle. Vet Microbiol (1986) 0.94
Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro. Proc Natl Acad Sci U S A (1983) 0.94
Extraction and characterization of IgG Fc receptors from group C and group G streptococci. Mol Immunol (1986) 0.94
Analysis of plasmin(ogen) acquisition by clinical isolates of group A streptococci incubated in human plasma. J Infect Dis (1994) 0.94